Biomarkers in neonatal infection

Area of Science:

• Neonatal Medicine
• Infectious Diseases
• Biomarker Discovery

Background:

• Distinguishing infected neonates from those with noninfective diseases is clinically challenging.
• Delayed antibiotic treatment in infected infants can be fatal, while overuse leads to resistance and complications.
• Current biomarkers like blood cell counts have significant limitations in diagnosing neonatal infections.

Purpose of the Study:

• To review emerging biomarkers for diagnosing neonatal infections.
• To evaluate the diagnostic utility and clinical relevance of novel biomarkers.
• To explore the prognostic value of these biomarkers in neonatal care.

Main Methods:

• Literature review of recent research on neonatal infection biomarkers.
• Discussion of major biomarker classes: acute phase reactants, cytokines, chemokines, and leukocyte surface antigens.
• Analysis of the application of these biomarkers for prognostic information.

Main Results:

• Novel biomarkers show potential for superior diagnostic accuracy compared to conventional methods.
• Specific biomarkers (e.g., cytokines, chemokines) are associated with infection status and severity.
• Prognostic information can be derived from these biomarkers, aiding clinical decision-making.

Conclusions:

• Emerging biomarkers offer enhanced diagnostic capabilities for neonatal infections.
• These biomarkers can assist clinicians in differentiating infected from noninfected infants.
• Further research and validation are needed to fully integrate these biomarkers into clinical practice.